Earnings Call Intelligence Subscribe
Home › Call Sheets › MDT › Q4'26
Call sheet · Q4'26

Medtronic (MDT)

Q4'26 earnings call · held June 3, 2026 · compared with the Q3'26 call · management-credibility review
12/12
Disclosure score
1 medium, 6 low flags
Financial quality
Bottom line
The sleeper story is MiniMed separation as a margin catalyst - removing a business with 'lower gross margin rate than the rest' creates structural improvement starting FY27. The obvious CAS success is real, but the bigger story is the margin mix finally turning positive in H2 FY27 as catheter sales outpace capital equipment. The binding constraint is mapper hiring to scale CAS installations, though they're 'staying ahead of it' with dedicated EP talent. Geoff's most revealing quote: 'Where other companies see a mature market, our Cardiac Rhythm Management sees opportunity and innovates and drives the market.' This captures their innovation-first approach across all segments. My view changes if Symplicity's 50x website traffic surge doesn't convert to meaningful procedure volumes in FY27.

The 30-second version

  • The MiniMed separation is actually a financial inflection catalyst hidden in plain sight
  • CAS is becoming a $2B run-rate business but the capital equipment drag is quietly improving
  • Symplicity crossed the $100M annualized threshold but the patient demand surge tells a bigger story

What changed this quarter

MetricQ3'26Q4'26Change
Revenue$9.0B Q3 (+6.0% organic YoY)$9.8B Q4 (+6.6% organic YoY)+60 bps acceleration on tougher comp
Adjusted EPS$1.36 Q3$1.55 Q4+$0.19 vs prior quarter, above guidance
CAS Growth80% Q378% Q4-200 bps but installed base +40% sequentially
Symplicity RevenueNot annualized$100M annualizedCrossed key milestone, doubled weekly volumes
Adjusted Gross Margin64.9% Q365.4% Q4+50 bps sequential expansion
Free Cash FlowNot disclosed Q3$5.4B FY26Strongest since 2022, ahead of expectations
Structural Heart GrowthLow single digit Q3Flat Q4Continued softness, but 'stabilized over last 8 weeks'
CST GrowthMid-single digit Q33% Q4Deceleration but Stealth AXiS launching Q4
Operating Margin24.1% Q325.5% Q4+140 bps expansion
CRM Growth5% Q35% Q4Consistent mid-single digit performance

Accountability tracked

8 new promises made5 narrative shifts flagged6 prior promises scored
Inside the full report
The complete write-up covers the full promise ledger with kept/missed calls, disclosure-quality scoring, the metrics-vanished check, verification items, and the questions to ask next quarter.
Read the full MDT Q4'26 report Subscribe
About Research ↗Call SheetsCredibility IndexMissed PromisesScreens13F BooksData & InstitutionalPrivacyTermsSubscribe
This is a free preview. The full write-up and promise ledger are published to subscribers on Substack.
Scores, kept-promise rates, and flags on this site reflect the author's opinion, applying a stated methodology to statements management made on public earnings calls. Informational and educational purposes only - not investment advice, a recommendation, or an offer to buy or sell any security. Sources believed reliable but not guaranteed; the author may hold positions in the securities discussed.

Follow what management promises next

Get free previews of our earnings-call research: the key changes, management scores, and questions worth investigating. Subscribe for full call sheets and deeper analysis.

Subscriptions are managed by Substack. If the form does not load, subscribe directly. Or follow the RSS feed.